150 related articles for article (PubMed ID: 29734838)
1. Discordant prostate specific antigen test results despite WHO assay standardization.
Boegemann M; Arsov C; Hadaschik B; Herkommer K; Imkamp F; Nofer JR; Gerß J; Albers P; Semjonow A
Int J Biol Markers; 2018 Aug; 33(3):275-282. PubMed ID: 29734838
[TBL] [Abstract][Full Text] [Related]
2. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.
Stephan C; Klaas M; Müller C; Schnorr D; Loening SA; Jung K
Clin Chem; 2006 Jan; 52(1):59-64. PubMed ID: 16391327
[TBL] [Abstract][Full Text] [Related]
3. Variability of assay methods for total and free PSA after WHO standardization.
Foj L; Filella X; Alcover J; Augé JM; Escudero JM; Molina R
Tumour Biol; 2014 Mar; 35(3):1867-73. PubMed ID: 24092573
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation.
Kort SA; Martens F; Vanpoucke H; van Duijnhoven HL; Blankenstein MA
Clin Chem; 2006 Aug; 52(8):1568-74. PubMed ID: 16762996
[TBL] [Abstract][Full Text] [Related]
5. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards.
Stephan C; Kahrs AM; Klotzek S; Reiche J; Müller C; Lein M; Deger S; Miller K; Jung K
Clin Chem Lab Med; 2008; 46(5):623-9. PubMed ID: 18839463
[TBL] [Abstract][Full Text] [Related]
6. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
[TBL] [Abstract][Full Text] [Related]
7. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
[TBL] [Abstract][Full Text] [Related]
9. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA.
Slev PR; La'ulu SL; Roberts WL
Am J Clin Pathol; 2008 Jun; 129(6):952-8. PubMed ID: 18480013
[TBL] [Abstract][Full Text] [Related]
10. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
Stephan C; Köpke T; Semjonow A; Lein M; Deger S; Schrader M; Miller K; Jung K
Clin Chem Lab Med; 2009; 47(11):1325-31. PubMed ID: 19778292
[TBL] [Abstract][Full Text] [Related]
11. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
Jung K; Stephan C; Elgeti U; Lein M; Brux B; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Sinha P
Int J Cancer; 2001 Sep; 93(5):759-65. PubMed ID: 11477592
[TBL] [Abstract][Full Text] [Related]
12. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Three Assays for Total and Free PSA Using Hybritech and WHO Calibrations.
Garrido MM; Marta JC; Ribeiro RM; Pinheiro LC; Holdenrieder S; Guimarães JT
In Vivo; 2021; 35(6):3431-3439. PubMed ID: 34697179
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays.
Fillée C; Tombal B; Philippe M
Clin Chem Lab Med; 2010 Feb; 48(2):285-8. PubMed ID: 20001849
[TBL] [Abstract][Full Text] [Related]
16. An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.
Stephan C; Cammann H; Meyer HA; Müller C; Deger S; Lein M; Jung K
BJU Int; 2008 Sep; 102(7):799-805. PubMed ID: 18522632
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
18. Elevated prostate specific antigen and reduced 10-year survival among a cohort of Danish men consecutively referred from primary care to an urological department during 2005-2006.
Hillig T; Nielsen TK; Hansen SI; Nygaard AB; Sölétormos G
Scand J Clin Lab Invest; 2017 Feb; 77(1):27-35. PubMed ID: 27762145
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
Okegawa T; Noda H; Nutahara K; Higashihara E
Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
[TBL] [Abstract][Full Text] [Related]
20. Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.
Parsons JK; Brawer MK; Cheli CD; Partin AW; Djavan R
BJU Int; 2004 Jul; 94(1):47-50. PubMed ID: 15217429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
